Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state?
Ferrier
I N
IN
Crow
T J
TJ
Farmery
S M
SM
Roberts
G W
GW
Owen
F
F
Adrian
T E
TE
Bloom
S R
SR
D002766:Cholecystokinin / Q000032:analysis* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008032:Limbic System / Q000032:analysis* / Q000473:pathology; D008297:Male; D009419:Nerve Tissue Proteins / Q000032:analysis; D011863:Radioimmunoassay; D011956:Receptors, Cell Surface / Q000032:analysis; D011949:Receptors, Cholecystokinin; D012559:Schizophrenia / Q000378:metabolism*
D009419:Nerve Tissue Proteins; D011956:Receptors, Cell Surface; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D004298:Dopamine